(VCBeat) Jan. 15, 2021 -- According to the report from 36Kr.com, recently, Ganlanzhi Jiankang (English meaning as "Olive Branch Health"), a digital service provider in the vaccine industry, raised nearly US$10 million in a Series A investment round, led by IDG Capital with participation from Next Capital. Ganlanzhi Jiankang plans to use the funds for product R&D, market promotion, and the digitalization of the vaccine industry, while vigorously strengthening the various needs of users and providing solutions to the vaccination problem through science popularization, consultation, and appointment online.
Founded in 2017, Ganlanzhi Jiankang is one of the first companies in China to develop digital services in the vaccine industry. By the end of 2020, the company has initially built a vaccination network covering China, including more than 20 provinces and 50 cities. Its service has been extended to the online reservation service of vaccination covering the whole category of non-immunization planned vaccines (Class II vaccines). At the same time, Ganlanzhi Jiankang has also developed third-party testing services based on the experience of online vaccination, with its business expanding to 20+ provinces and 60+ cities in China.
At a time when domestic demand for vaccination is at an all-time high, the vaccine industry is in dire need of digital solutions to address the mismatch between supply and demand. The "Internet + Vaccine" platform created by Ganlanzhi Jiankang cooperates with medical institutions to provide users with online services. Through system docking, observation data and vaccination prognosis data, Ganlanzhi Jiankang has formed a closed-loop industry chain and the vaccination rate has been comprehensively improved.
At present, Ganlanzhi Jiankang has joined hands with multiple online platforms to deliver vaccine digital services, including Ali Health, Jingdong Health, Tencent Health, Baidu Health, Bytedance, Meituan, and Pinduoduo, and build the digital vaccine market together.
About IDG Capital
IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world.
About Next Capital
Next Capital focuses on early-stage investment in the field of technology. They seek new players in traditional industries, as well as pioneers in new tracks. They firmly believe that "technology drives business change". To give "Innovator's First Money" in the angel round, Next Capital wants to shake hands with The young people who have the potential to become future business leaders and to create "The Next Big Thing" with the power of innovation.
View original content to download multimedia: https://36kr.com/p/1054625212240001